Contact Us
Request Access
  1. Home
  2. News – Rx-360 Alerts

News – Rx-360 Alerts

DEA’s National Take Back Day – April 27th 2019 @ 10:00am
FDA: Safe Opioid Disposal – Remove the Risk Outreach Toolkit
Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan…
FDA Warns CanaRx for Selling Unapproved, Misbranded and Unsafe Imported Drugs to Unsuspecting Americans
Memorandum on Combating Trafficking in Counterfeit and Pirated Goods
Fraudulent Correspondence – Warning to all Members & Non-Members
FDA Says Up to Two Million People Exposed to Likely Carcinogens in Blood-Pressure Drugs
Revisoin 7 of ICH Q3C Guideline for Residual Solvents
Five additional countries to benefit from EU-US mutual recognition agreement for inspections | European Medicines…
Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP
Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality…
FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications
Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets
Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s efforts to hold industry accountable…
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide